220 related articles for article (PubMed ID: 20380651)
1. Bioengineered skin in diabetic foot ulcers.
Teng YJ; Li YP; Wang JW; Yang KH; Zhang YC; Wang YJ; Tian JH; Ma B; Wang JM; Yan X
Diabetes Obes Metab; 2010 Apr; 12(4):307-15. PubMed ID: 20380651
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
Jude EB; Apelqvist J; Spraul M; Martini J;
Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
[TBL] [Abstract][Full Text] [Related]
3. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
[TBL] [Abstract][Full Text] [Related]
4. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes.
Khaodhiar L; Dinh T; Schomacker KT; Panasyuk SV; Freeman JE; Lew R; Vo T; Panasyuk AA; Lima C; Giurini JM; Lyons TE; Veves A
Diabetes Care; 2007 Apr; 30(4):903-10. PubMed ID: 17303790
[TBL] [Abstract][Full Text] [Related]
5. The role of stem cells in the treatment of diabetic foot ulcers.
Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W
Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631
[TBL] [Abstract][Full Text] [Related]
6. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
[TBL] [Abstract][Full Text] [Related]
7. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.
Snyder RJ; Cardinal M; Dauphinée DM; Stavosky J
Ostomy Wound Manage; 2010 Mar; 56(3):44-50. PubMed ID: 20368673
[TBL] [Abstract][Full Text] [Related]
8. Diabetic foot ulcers--effects on QOL, costs, and mortality and the role of standard wound care and advanced-care therapies.
Snyder RJ; Hanft JR
Ostomy Wound Manage; 2009 Nov; 55(11):28-38. PubMed ID: 19934461
[TBL] [Abstract][Full Text] [Related]
9. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
Saap LJ; Donohue K; Falanga V
Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
[TBL] [Abstract][Full Text] [Related]
10. [Healing of skin lesions in diabetic foot syndrome during hospitalization].
Jirkovská A
Vnitr Lek; 2006 May; 52(5):459-64. PubMed ID: 16771090
[TBL] [Abstract][Full Text] [Related]
11. Principles of management: the diabetic foot.
Wieman TJ
Am J Surg; 2005 Aug; 190(2):295-9. PubMed ID: 16023449
[TBL] [Abstract][Full Text] [Related]
12. Present and new techniques and devices in the treatment of DFU: a critical review of evidence.
Gottrup F; Apelqvist J
Diabetes Metab Res Rev; 2012 Feb; 28 Suppl 1():64-71. PubMed ID: 22271726
[TBL] [Abstract][Full Text] [Related]
13. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
Reyzelman AM; Bazarov I
J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
[TBL] [Abstract][Full Text] [Related]
14. Bioengineered alternative tissues and hyperbaric oxygen in lower extremity wound healing.
Kim PJ; Heilala M; Steinberg JS; Weinraub GM
Clin Podiatr Med Surg; 2007 Jul; 24(3):529-46, x. PubMed ID: 17613390
[TBL] [Abstract][Full Text] [Related]
15. Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer.
Marston WA
Expert Rev Med Devices; 2004 Sep; 1(1):21-31. PubMed ID: 16293007
[TBL] [Abstract][Full Text] [Related]
16. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
[TBL] [Abstract][Full Text] [Related]
18. Protocol for treatment of diabetic foot ulcers.
Brem H; Sheehan P; Boulton AJ
Am J Surg; 2004 May; 187(5A):1S-10S. PubMed ID: 15147985
[TBL] [Abstract][Full Text] [Related]
19. Using hyperbaric oxygen to treat diabetic foot ulcers: safety and effectiveness.
Heyneman CA; Lawless-Liday C
Crit Care Nurse; 2002 Dec; 22(6):52-60. PubMed ID: 12518568
[No Abstract] [Full Text] [Related]
20. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial.
Piaggesi A; Schipani E; Campi F; Romanelli M; Baccetti F; Arvia C; Navalesi R
Diabet Med; 1998 May; 15(5):412-7. PubMed ID: 9609364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
